Research Paper Volume 14, Issue 7 pp 3233—3258

Figure 2. A negative correlation between ALDOA and FBP1 exists in LUAD and LIHC patients. (A) The heatmap shows the expression of ALDOA and FBP1 in TCGA lung adenocarcinoma (LUAD) patients. (B) The related expression of ALDOA and FBP1 in the normal and LUAD tumor groups in TCGA lung adenocarcinoma (LUAD). (C) A paired analysis reveals the difference between ALDOA and FBP1 in TCGA lung adenocarcinoma (LUAD). (D) The correlation between ALDOA and FBP1 in TCGA lung adenocarcinoma (LUAD). (E) A paired analysis revealed the difference between ALDOA and FBP1 in GSE7670. (F) The heatmap shows the related expression of ALDOA and FBP1 in TCGA Liver Cancer (LIHC) patients. (G) The related expression of ALDOA and FBP1 in normal and LIHC tumor groups in TCGA Liver Cancer (LIHC). (H) A paired analysis revealed the difference between ALDOA and FBP1 in TCGA Liver Cancer (LIHC). (I) The correlation between ALDOA and FBP1 in TCGA Liver Cancer (LIHC). (J) A paired analysis revealed the difference between ALDOA and FBP1 in GSE84402. The significance of the differences in (B, C, E, G, H, J) was analyzed using unpaired Student’s t-tests. The significance of the differences in (D, I) was analyzed using Spearman's rank correlation coefficient. N or n is denoted as sample size.